医保改革后，个人账户划入减少？药店也都快撑不住

Core Insights - The domestic pharmacy industry is facing a significant downturn, with a sharp increase in store closures, totaling 6,778 in Q1 2024 and rising to 8,792 in Q2 2024 [1][4] Group 1: Market Conditions - The oversaturation of pharmacies is a critical factor contributing to the industry's struggles, as the stable demand for pharmaceuticals is divided among an excessive number of stores, leading to reduced profit margins [4] - As of Q2 2023, the total number of pharmacies in China reached 701,000, which translates to an average of about 2,000 people served per pharmacy, significantly lower than the 6,000-7,000 range in developed countries [8] Group 2: Impact of Healthcare Policy - The reform of the medical insurance system, particularly the changes to personal accounts since 2021, has severely impacted consumer spending at pharmacies, as funds from personal accounts have decreased, leading to a decline in pharmacy revenues [6][9] - In 2023, the expenditure from personal accounts for purchasing medications dropped by 9% year-on-year, and this trend is expected to continue into 2024, further straining pharmacy revenues [8] Group 3: Consumer Behavior - Consumers are increasingly opting to visit hospitals for medication due to insufficient balances in their medical insurance accounts, which allows them to benefit from broader reimbursement options [8] - The reduction in personal account contributions has made consumers more price-sensitive, prompting them to seek lower-priced medications and compare prices more rigorously [8]